EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy

Hiromi Ga, Ayumi Taguchi iD, Harunori Honjoh, Akira Nishijima, Satoko Eguchi, Yuichiro Miyamoto, Kenbun Sone, Mayuyo Mori, Yutaka Osuga

Archives of Gynecology and Obstetrics · 2023

DOI: 10.1007/s00404-023-07077-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2023. Verfasst von Hiromi Ga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Fertility Preservation, Endometrial Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Osaka University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although many patients with endometrial cancer (EC) or atypical endometrial hyperplasia (AEH) achieve complete remission (CR) after high-dose medroxyprogesterone acetate (MPA) treatment, no consensus has been reached on management after CR. Currently, patients receive estrogen-progestin maintenance therapy, but no recommendations exist regarding the duration of maintenance therapy or whether hysterectomy should be considered. This study aimed to provide insights into the management of EC/AEH after achieving CR.

Methods

We retrospectively investigated the prognosis of 50 patients with EC or AEH who achieved CR after MPA therapy. We assessed the association between disease recurrence and clinicopathological features and the pre- and post-operative histological diagnoses of patients who underwent hysterectomy.

Results

The median follow-up duration was 34 months (range: 1–179 months). Recurrence was observed in 17 patients. Among the clinical characteristics investigated, only the primary disease was significantly associated with disease recurrence; patients with EC had a higher risk of recurrence than those with AEH ( p = 0.037). During the observation period, 27 patients attempted pregnancy, and 14 pregnancies resulted in delivery. Patients who gave birth had significantly longer relapse-free survivals than those who did not ( p = 0.031). Further, 16 patients underwent hysterectomies, and AEH was detected postoperatively in 4 of 11 patients (36.4%) with no preoperative abnormalities.

Conclusions

We identified several clinical features of patients with EC and AEH after CR. Given the high probability of endometrial abnormalities detected postoperatively, hysterectomy may be considered for patients who no longer want children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial HyperplasiaFertility PreservationEndometrial NeoplasmsPregnancyFemaleChildHumansRetrospective StudiesTreatment OutcomeNeoplasm Recurrence, LocalMedroxyprogesterone AcetatePrognosis

Stichwörter der Autor:innen

Fertility-sparing therapyHysterectomyManagement after complete remissionRecurrence

Substanzen

Medroxyprogesterone Acetate

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-Ku, Tokyo, 113-8655, Japan. ayumikidu246@gmail.com.
  • Laboratory of Human Single Cell Immunology, World Premier International Immunology Frontier Research Center (WPI-IFReC), Osaka University, 3-1 Yamadaoka Suita-shi, Osaka, 565-0871, Japan. ayumikidu246@gmail.com.

ORCID-Profile: Ayumi Taguchi

Förderung

  • Osaka University

Zitieren

APA

Ga, H., Taguchi, A., Honjoh, H., Nishijima, A., Eguchi, S., Miyamoto, Y., Sone, K., Mori, M., & Osuga, Y. (2023). Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-07077-7

Vancouver

Ga H, Taguchi A, Honjoh H, Nishijima A, Eguchi S, Miyamoto Y, et al. Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy. Archives of Gynecology and Obstetrics. 2023. doi:10.1007/s00404-023-07077-7

BibTeX
@article{Ga2023,
  author = {Ga, Hiromi and Taguchi, Ayumi and Honjoh, Harunori and Nishijima, Akira and Eguchi, Satoko and Miyamoto, Yuichiro and Sone, Kenbun and Mori, Mayuyo and Osuga, Yutaka},
  title = {Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2023},
  doi = {10.1007/s00404-023-07077-7}
}
Kostenlos starten →